185 related articles for article (PubMed ID: 35462473)
1. Ch25h and 25-HC prevent liver steatosis through regulation of cholesterol metabolism and inflammation.
Wang Y; Zhang J; Chen J; Wang D; Yu Y; Qiu P; Wang Q; Zhao W; Li Z; Lei T
Acta Biochim Biophys Sin (Shanghai); 2022 Apr; 54(4):504-513. PubMed ID: 35462473
[TBL] [Abstract][Full Text] [Related]
2. Hepatic Reduction in Cholesterol 25-Hydroxylase Aggravates Diet-induced Steatosis.
Dong Z; He F; Yan X; Xing Y; Lei Y; Gao J; He M; Li D; Bai L; Yuan Z; Y-J Shyy J
Cell Mol Gastroenterol Hepatol; 2022; 13(4):1161-1179. PubMed ID: 34990887
[TBL] [Abstract][Full Text] [Related]
3. Asperuloside alleviates lipid accumulation and inflammation in HFD-induced NAFLD via AMPK signaling pathway and NLRP3 inflammasome.
Shen Q; Chen Y; Shi J; Pei C; Chen S; Huang S; Li W; Shi X; Liang J; Hou S
Eur J Pharmacol; 2023 Mar; 942():175504. PubMed ID: 36641101
[TBL] [Abstract][Full Text] [Related]
4. Steatosis, inflammasome upregulation, and fibrosis are attenuated in miR-155 deficient mice in a high fat-cholesterol-sugar diet-induced model of NASH.
Bala S; Ganz M; Babuta M; Zhuang Y; Csak T; Calenda CD; Szabo G
Lab Invest; 2021 Dec; 101(12):1540-1549. PubMed ID: 34453120
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol Accumulation as a Driver of Hepatic Inflammation Under Translational Dietary Conditions Can Be Attenuated by a Multicomponent Medicine.
Mueller AM; Kleemann R; Gart E; van Duyvenvoorde W; Verschuren L; Caspers M; Menke A; Krömmelbein N; Salic K; Burmeister Y; Seilheimer B; Morrison MC
Front Endocrinol (Lausanne); 2021; 12():601160. PubMed ID: 33815271
[TBL] [Abstract][Full Text] [Related]
6. Schaftoside alleviates HFD-induced hepatic lipid accumulation in mice via upregulating farnesoid X receptor.
Liu M; Zhang G; Wu S; Song M; Wang J; Cai W; Mi S; Liu C
J Ethnopharmacol; 2020 Jun; 255():112776. PubMed ID: 32205261
[TBL] [Abstract][Full Text] [Related]
7. 25-hydroxycholesterol contributes to cerebral inflammation of X-linked adrenoleukodystrophy through activation of the NLRP3 inflammasome.
Jang J; Park S; Jin Hur H; Cho HJ; Hwang I; Pyo Kang Y; Im I; Lee H; Lee E; Yang W; Kang HC; Won Kwon S; Yu JW; Kim DW
Nat Commun; 2016 Oct; 7():13129. PubMed ID: 27779191
[TBL] [Abstract][Full Text] [Related]
8. Apigenin ameliorates HFD-induced NAFLD through regulation of the XO/NLRP3 pathways.
Lv Y; Gao X; Luo Y; Fan W; Shen T; Ding C; Yao M; Song S; Yan L
J Nutr Biochem; 2019 Sep; 71():110-121. PubMed ID: 31325892
[TBL] [Abstract][Full Text] [Related]
9. Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota in NAFLD rats.
Zhong M; Yan Y; Yuan H; A R; Xu G; Cai F; Yang Y; Wang Y; Zhang W
Food Funct; 2022 Jul; 13(13):7287-7301. PubMed ID: 35726797
[TBL] [Abstract][Full Text] [Related]
10. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J
J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220
[TBL] [Abstract][Full Text] [Related]
11. 5-cholesten-3β,25-diol 3-sulfate decreases lipid accumulation in diet-induced nonalcoholic fatty liver disease mouse model.
Xu L; Kim JK; Bai Q; Zhang X; Kakiyama G; Min HK; Sanyal AJ; Pandak WM; Ren S
Mol Pharmacol; 2013 Mar; 83(3):648-58. PubMed ID: 23258548
[TBL] [Abstract][Full Text] [Related]
12. Macrophage-Derived 25-Hydroxycholesterol Promotes Vascular Inflammation, Atherogenesis, and Lesion Remodeling.
Canfrán-Duque A; Rotllan N; Zhang X; Andrés-Blasco I; Thompson BM; Sun J; Price NL; Fernández-Fuertes M; Fowler JW; Gómez-Coronado D; Sessa WC; Giannarelli C; Schneider RJ; Tellides G; McDonald JG; Fernández-Hernando C; Suárez Y
Circulation; 2023 Jan; 147(5):388-408. PubMed ID: 36416142
[TBL] [Abstract][Full Text] [Related]
13. Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis.
Malhotra P; Aloman C; Ankireddy A; Khadra H; Ooka K; Gill RK; Saksena S; Dudeja PK; Alrefai WA
Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G376-G385. PubMed ID: 28774869
[TBL] [Abstract][Full Text] [Related]
14. PTUPB ameliorates high-fat diet-induced non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in mice.
Sun CC; Zhang CY; Duan JX; Guan XX; Yang HH; Jiang HL; Hammock BD; Hwang SH; Zhou Y; Guan CX; Liu SK; Zhang J
Biochem Biophys Res Commun; 2020 Mar; 523(4):1020-1026. PubMed ID: 31973813
[TBL] [Abstract][Full Text] [Related]
15. Carnosic acid protects mice from high-fat diet-induced NAFLD by regulating MARCKS.
Song HM; Li X; Liu YY; Lu WP; Cui ZH; Zhou L; Yao D; Zhang HM
Int J Mol Med; 2018 Jul; 42(1):193-207. PubMed ID: 29620148
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rg1 Protects against Non-alcoholic Fatty Liver Disease by Ameliorating Lipid Peroxidation, Endoplasmic Reticulum Stress, and Inflammasome Activation.
Xu Y; Yang C; Zhang S; Li J; Xiao Q; Huang W
Biol Pharm Bull; 2018 Nov; 41(11):1638-1644. PubMed ID: 30135326
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development.
He K; Zhu X; Liu Y; Miao C; Wang T; Li P; Zhao L; Chen Y; Gong J; Cai C; Li J; Li S; Ruan XZ; Gong J
Oncotarget; 2017 Jun; 8(23):37657-37672. PubMed ID: 28499273
[TBL] [Abstract][Full Text] [Related]
18. Apigenin attenuates atherosclerosis and non-alcoholic fatty liver disease through inhibition of NLRP3 inflammasome in mice.
Lu Z; Liu L; Zhao S; Zhao J; Li S; Li M
Sci Rep; 2023 May; 13(1):7996. PubMed ID: 37198205
[TBL] [Abstract][Full Text] [Related]
19. Hepatic Deficiency of Augmenter of Liver Regeneration Predisposes to Nonalcoholic Steatohepatitis and Fibrosis.
Kumar S; Verma AK; Rani R; Sharma A; Wang J; Shah SA; Behari J; Salazar Gonzalez R; Kohli R; Gandhi CR
Hepatology; 2020 Nov; 72(5):1586-1604. PubMed ID: 32031683
[TBL] [Abstract][Full Text] [Related]
20. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.
Zhang R; Yu Y; Hu S; Zhang J; Yang H; Han B; Cheng Y; Luo X
Nutr Res; 2016 Sep; 36(9):1022-1030. PubMed ID: 27632923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
